506365 — Chemo Pharma Laboratories Share Price
0.000.00%
Last trade - 00:00- IN₹200.93m
- IN₹133.39m
- 38
- 22
- 89
- 49
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.47 | ||
| Price to Tang. Book | 1.47 | ||
| Price to Free Cashflow | 23.34 | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1.44% | ||
| Return on Equity | 2.99% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | +2437.7 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Chemo Pharma Laboratories Limited is an India-based company. The Company was engaged in manufacturing operations. It has no operations and does not generate any revenue. The Company is exploring new business opportunities.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 17th, 1942
- Public Since
- January 2nd, 1995
- Sector
- Holding Companies
- Industry
- Financials
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 1,500,000
- Address
- Empire House, MUMBAI, 400001
- Web
- https://www.thechemopharmalaboratoriesltd.com/
- Phone
- +91 2222078382
- Auditors
- Sanjay Rane & Associates
Upcoming Events for 506365
Q1 2026 Chemo Pharma Laboratories Ltd Earnings Release
Chemo Pharma Laboratories Ltd Annual Shareholders Meeting
Q2 2026 Chemo Pharma Laboratories Ltd Earnings Release
Similar to 506365
Ace Engitech
Bombay Stock Exchange
Advance Powerinfra Tech
Bombay Stock Exchange
Amerise Biosciences
Bombay Stock Exchange
Amraworld Agrico
Bombay Stock Exchange
Balmer Lawrie Investments
Bombay Stock Exchange
FAQ
What is the Chemo Pharma Laboratories share price?
As of Today at 19:53 UTC, shares in Chemo Pharma Laboratories are trading at IN₹133.95. This share price information is delayed by 15 minutes.
How has the Chemo Pharma Laboratories share price performed this year?
Shares in Chemo Pharma Laboratories last closed at IN₹133.95 and the price had moved by +62.17% over the past 365 days. In terms of relative price strength the Chemo Pharma Laboratories share price has outperformed the S&P BSE 100 Index by +52.76% over the past year.
What are the analyst and broker recommendations for Chemo Pharma Laboratories?
There is no consensus recommendation for this security.
Find out moreWhat is the Chemo Pharma Laboratories dividend yield?
Chemo Pharma Laboratories does not currently pay a dividend.
Does Chemo Pharma Laboratories pay a dividend?
Chemo Pharma Laboratories does not currently pay a dividend.
When does Chemo Pharma Laboratories next pay dividends?
Chemo Pharma Laboratories does not currently pay a dividend.
How do I buy Chemo Pharma Laboratories shares?
To buy shares in Chemo Pharma Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Chemo Pharma Laboratories?
As of the previous close price of IN₹133.95, shares in Chemo Pharma Laboratories had a market capitalisation of IN₹200.93m.
Where are Chemo Pharma Laboratories shares listed?
Here are the trading details for Chemo Pharma Laboratories:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 506365
What kind of share is Chemo Pharma Laboratories?
Based on an overall assessment of its quality, value and momentum Chemo Pharma Laboratories is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Chemo Pharma Laboratories share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Chemo Pharma Laboratories share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Chemo Pharma Laboratories. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +104.16%.
As of the last closing price of IN₹133.95, shares in Chemo Pharma Laboratories were trading +56.46% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Chemo Pharma Laboratories PE Ratio?
The Chemo Pharma Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹133.95.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Chemo Pharma Laboratories?
We do not have data on Chemo Pharma Laboratories' directors